Aldevron

As mRNA-based medicines move toward clinical development stages, the question of defining quality attributes and analytical testing procedures become ever more important. As part of an ongoing series discussing mRNA manufacturing, Nate Spangler looks at the state of those elements and what the future could hold for implementation. https://ald.bio/3URyB5x

We are a proud gold-level sponsor the12th annual meeting of the International mRNA Health Conference! This high-impact event runs November 12 - 14, in Boston, and provides participants an opportunity to learn more about developments in mRNA technologies through scientific presentations by some of the most esteemed experts in the field and extensive networking opportunities. #mRNA Our team is ready to connect to learn more how we can support your mRNA breakthroughs! Jacob Campbell Tao Lu Jon Cooper, PhD Joelle Ertl Mark Wetzel Matt I. Mark Lobas Nathan Spangler

Discover how Aldevron can support your cell and gene therapy development from discovery through to clinic and commercialization. Whatever stage your program is at, let Aldevron be your partner for the journey. 

Effectively eliminate the cost and timeline of a custom nuclease for your CRISPR-based therapy with Aldevron’s ready-to-use nucleases, available at research and cGMP and cGMP grades! We have a variety of nucleases for your gene editing needs that will help reduce regulatory filing paperwork with existing Drug Master Files (DMFs) and support a smooth transition to clinical applications. And for a limited time, we’re offering a 32% discount on research grade products! https://ald.bio/3ClGzNO #Therapeutics #cGMP #ClinicalResearch

Don’t miss the mRNA International Health Conference starting Tuesday, November 12 in Boston, as the top mRNA experts from around the world meet to discuss what’s next for this exciting modality. Meet Aldevron’s experts at booth 2 and join us for Tao Lu’s presentation, From Template to Final Product: Strategies for mRNA Manufacturing on Thursday. https://ald.bio/3C1WJw1

Meet up with Aldevron's European experts in Liverpool 19-21 November at the biProcessUK Conference. Join us at booth 30 as Stuart King and other team members will be available to discuss your programs and how Aldevron can assist you in meeting your project goals. We look forwards to discussing your latest project. https://ald.bio/4hwPufG

Want to learn more about the use of Aldevron Nanoplasmids™ as highly efficient HDR donor templates? Join Integrated DNA Technologies’ upcoming FREE webinar to explore the benefits and optimization strategies for using Nanoplasmids™ as donor templates for large insertions in CRISPR-mediated HDR. The link to register is below!

Did you know that 40-50% of CGT programs that enter Phase III experience a disruption or hold thanks to CMC issues and more? Taking the right steps from the beginning of your program will help mitigate these risks. Our latest whitepaper explores challenges for CGT development, alongside ways to avoid common pitfalls. Download it now! https://ald.bio/4hxtyRq

What a great story about our very own Nate Russart, and how he ran the New York City Marthon with the purpose of supporting the Emily Whitehead Foundation! https://lnkd.in/gWVMVZX7

Working on a CRISPR-based therapy? We can help ease the transition to the clinic with standardized nucleases! Our nucleases are available at both research and cGMP grades to facilitate the move to clinical trials. Simplify your journey from bench to bedside. We're also offering a 32% limited-time discount on research grade products! https://ald.bio/4fr9zSB #CRISPR #GeneEditing #Biotech #ClinicalResearch